1. Home
  2. NYMTL vs CMMB Comparison

NYMTL vs CMMB Comparison

Compare NYMTL & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYMTL
  • CMMB
  • Stock Information
  • Founded
  • NYMTL N/A
  • CMMB 2004
  • Country
  • NYMTL United States
  • CMMB Israel
  • Employees
  • NYMTL 79
  • CMMB N/A
  • Industry
  • NYMTL Real Estate Investment Trusts
  • CMMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • NYMTL Real Estate
  • CMMB Health Care
  • Exchange
  • NYMTL Nasdaq
  • CMMB Nasdaq
  • Market Cap
  • NYMTL N/A
  • CMMB 37.3M
  • IPO Year
  • NYMTL N/A
  • CMMB N/A
  • Fundamental
  • Price
  • NYMTL $22.07
  • CMMB $1.90
  • Analyst Decision
  • NYMTL
  • CMMB Strong Buy
  • Analyst Count
  • NYMTL 0
  • CMMB 2
  • Target Price
  • NYMTL N/A
  • CMMB $7.50
  • AVG Volume (30 Days)
  • NYMTL N/A
  • CMMB 792.4K
  • Earning Date
  • NYMTL N/A
  • CMMB 03-06-2025
  • Dividend Yield
  • NYMTL N/A
  • CMMB N/A
  • EPS Growth
  • NYMTL N/A
  • CMMB N/A
  • EPS
  • NYMTL N/A
  • CMMB N/A
  • Revenue
  • NYMTL N/A
  • CMMB N/A
  • Revenue This Year
  • NYMTL N/A
  • CMMB N/A
  • Revenue Next Year
  • NYMTL N/A
  • CMMB N/A
  • P/E Ratio
  • NYMTL N/A
  • CMMB N/A
  • Revenue Growth
  • NYMTL N/A
  • CMMB N/A
  • 52 Week Low
  • NYMTL N/A
  • CMMB $0.58
  • 52 Week High
  • NYMTL N/A
  • CMMB $2.55
  • Technical
  • Relative Strength Index (RSI)
  • NYMTL 47.49
  • CMMB 42.77
  • Support Level
  • NYMTL $22.00
  • CMMB $1.86
  • Resistance Level
  • NYMTL $22.30
  • CMMB $2.06
  • Average True Range (ATR)
  • NYMTL 0.30
  • CMMB 0.15
  • MACD
  • NYMTL 0.01
  • CMMB -0.02
  • Stochastic Oscillator
  • NYMTL 35.48
  • CMMB 38.30

About NYMTL New York Mortgage Trust Inc. 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock $0.01 par value per share

New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Share on Social Networks: